skip-to-main

SPIKEVAX BIVALENT ORIGINAL/OMICRON (ELASOMERAN/IMELASOMERAN) COVID-19 VACCINE

SPIKEVAX BIVALENT ORIGINAL/OMICRON (elasomeran/imelasomeran) COVID-19 Vaccine has provisional approval for the indication below:

As a booster dose for active immunisation to prevent coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 in individuals 18 years of age and older.

Product Information

Product Information

Consumer Medicine Information

Consumer Medicine Information

Spikevax (previously COVID‑19 Vaccine Moderna)

SPIKEVAX (elasomeran) COVID-19 Vaccine has provisional approval for the indication below:

Active immunisation to prevent coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 in individuals 6 months of age and older.

Product Information

Product Information

Consumer Medicine Information

Consumer Medicine Information

Contact Moderna